Clinical Trial: Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a

Brief Summary: This study was designed to compare the efficacy, perception, decision making, and cost-effectiveness of genomic and non-genomic approaches for risk assessment of prostate cancer and for chemoprevention of prostate cancer.